About Us

We are dedicated to advancing bone regeneration.

With a profound understanding of complex biological processes, our team combines specialized expertise, rigorous research, and creative thinking to develop solutions that enhance the body’s physiological healing mechanisms, achieving the desired balance.

aboutus-orthotreat

Sahar Meiron

Co-founder & Chief Executive Officer

Liat Hadad

Chief Business Officer

Prof. Mansoor Khan

Chief Medical Officer 

Dr. Karl Rudolf Erlemann

Chief Scientific Officer

Dr. Christopher Wilson

Chief Technical & Quality Officer

Joshua Shlomiuk

Chief Financial Officer

Dr. Ronit Shaltiel-Karyo

Vice President of Research & Development

Adi Mondshine

Non-Clinical Manager

Liya Rak

Business & Operation Associate

Rebecca Hebden

CMC Project Manager

Dr. Hilik Marom, DVM

Co-Founder &
 Innovation Director

Dr. Tami Ehrmann Barr

Co-Founder

BOARD OF DIRECTORS

Dr. Nicholas Pachuda

Nissim Darvish, M.D., Ph.D

Ms. Aurore Andre

Mr. Martin Jepson

Dr. Hilik Marom, DVM

Mr. Sahar Meiron

SCIENTIFIC ADVISORY BOARD

CP logos

Dr. Christian POLICARD

SANOFI | INSTITUT PASTEUR

in
PT logos

Prof. Paul TORNETTA

BOSTON MEDICAL CENTER | AMERICAN ACADEMY OF ORTHOPEDIC SURGEONS

in
EV logos

Dr. Emmanuelle VOISIN

VOISIN CONSULTING
LIFE SCIENCE | FDA
in
The-University-of-South-Dakota-Sanford-School-of-Medicine-Interview-Prep

Dr. Nathan SKELLEY

SANFORD HEALTH
ORTHOPAEDICS MEDICINE
in
CHRIS ARTS LOGOS@1080x
Prof. Chris Arts

MAASTRICHT UMC+ & EINDHOVEN UNIVERSITY OF TECHNOLOGY

in
PATHO-LOGICA logo

Dr. Emmanuel Loeb

PATHO-LOGICA – EXPERIMENTAL PATHOLOGY LABORATORY

in
Tel_Aviv_Sourasky_Medical_Center.svg
Prof. Amal KHOURY

TEL AVIV SOURASKY
MEDICAL CENTER

in
HadassahLogo20202-1_11zon

Prof. Yoram WEIL

HADASSAH UNIVERSITY
MEDICAL CENTER

in
Philadelphia_76ers_logo.svg

Dr. Nicholas DINUBILE

76ERS | AMERICAN COUNCIL
ON EXERCISE (ACE)

in
RB logos

Ronnie BIRNBOIM

SANOFI | AMERICAN MEDICAL PROGRAM TEL AVIV UNIVERSITY

in
About Us
The science
Focus Area

WeWork Hazerem,
7 Hapelech st. 6816727
Tel Aviv Jaffa, Israel

 


All rights reserved 2024

About Us
At the core
The Platform
Knowledge Center
OrthoTalk
Sustainability
Contact Us
Follow us
x
סייען נגישות
הגדלת גופן
הקטנת גופן
גופן קריא
גווני אפור
גווני מונוכרום
איפוס צבעים
הקטנת תצוגה
הגדלת תצוגה
איפוס תצוגה

אתר מונגש

אנו רואים חשיבות עליונה בהנגשת אתר האינטרנט שלנו לאנשים עם מוגבלויות, וכך לאפשר לכלל האוכלוסיה להשתמש באתרנו בקלות ובנוחות. באתר זה בוצעו מגוון פעולות להנגשת האתר, הכוללות בין השאר התקנת רכיב נגישות ייעודי.

סייגי נגישות

למרות מאמצנו להנגיש את כלל הדפים באתר באופן מלא, יתכן ויתגלו חלקים באתר שאינם נגישים. במידה ואינם מסוגלים לגלוש באתר באופן אופטימלי, אנה צרו איתנו קשר

רכיב נגישות

באתר זה הותקן רכיב נגישות מתקדם, מבית all internet - בניית אתרים. רכיב זה מסייע בהנגשת האתר עבור אנשים בעלי מוגבלויות.

Sahar Meiron

Chief Executive Officer & Co-Founder

Sahar is an entrepreneur with strong business acumen and a broad, self-taught knowledge of pharmaceutical innovation. He successfully launched and managed a CBD brand for pets within a publicly-traded European veterinary company. As the Co-Founder of Treat Group, a holding company dedicated to improving health through innovation for humans, animals, and the environment, Sahar brings a wealth of experience to the table. Sahar studied Biology at the Israel Open University, specialized in Drug Development at UC San Diego, and pursued additional business studies at Jolt.io.

Liat Hadad

Chief Business Officer

Liat is a seasoned executive with over two decades of experience in the Life Sciences industry. Her diverse background spans innovation, investments, business development, and marketing across various sectors including pharma, digital health, bioconvergence, and medical devices. As Chief Business Officer at OrthoTreat, she currently leads the development of innovative bone regeneration therapies. Liat has held key positions at Sanara Ventures, Ramot [Tel Aviv University’s Business Engagement Center], Lumenis, Allium Medical, and Giza Venture Capital.  Liat holds a B.A. in sociology, anthropology, and political science, as well as an Executive M.B.A. in entrepreneurial studies, marketing, and finance from Tel Aviv University.

Prof. Mansoor Khan

Chief Medical Officer

Mansoor combines his expertise as a trauma surgeon with his roles as an innovator, entrepreneur, and investor. Formerly the Head of Surgery for the Royal Navy and trauma surgeon for the Abu Dhabi Formula One Grand Prix, he also serves as Course Director for the Definitive Surgical Trauma Skills Course. Prof. Khan is deeply involved in trauma-based research, international trauma training, and corporate advisory roles. 
He holds an MBBS from King’s College London, a Ph.D. in Medicine from the University of Warwick, and an EMBA from Northampton University.

Dr. Karl-Rudolf Erlemann

Chief Scientific Officer

Dr. Erlemann is a biopharma executive with over 20 years of experience across drug discovery, preclinical development, and external innovation. He currently serves as OrthoTreat’s Interim Chief Scientific Officer, where he guides scientific strategy and oversees the development programs.

Dr. Erlemann is also the founder of KreaMedica, a consultancy providing tailored drug development solutions to biotech and pharma companies. He previously served as VP of Business Development and Scientific Affairs at InSymbiosis, and held senior scientific roles at Charles River Laboratories, specializing in DMPK and translational research.

He holds a Ph.D. in biochemistry from Humboldt University, with research conducted at McGill University, and an M.Sc. in biophysics.

Dr. Christopher Wilson

Chief Technical & Quality Officer

Dr. Wilson is a senior medical device and combination-product executive with over 15 years of experience spanning development strategies, quality systems, and operational leadership. He currently serves as OrthoTreat’s Chief Technical & Quality Officer, where he leads CMC and quality strategy, supporting the transition from preclinical development into clinical execution.

Dr. Wilson brings deep hands-on expertise across FDA and EU MDR frameworks, GMP aseptic manufacturing, and ISO 13485 quality systems, with a proven track record guiding Class II and III products through clinical development and market introduction. He previously held senior leadership roles at Sinclair Pharma and Smith & Nephew, and founded Listerdale Life Sciences, advising biotech and medtech companies on regulatory execution, scale-up, and fundraising.

He holds a Ph.D. in materials science, an MChem in drug design and toxicology, and executive training in health economics and policy.

Joshua Shlomiuk

Chief Financial Officer

Josh brings over 30 years of expertise in corporate finance, business strategy, advisory, and business development across diverse sectors, including energy, technology, agriculture, fintech, pharma, and communications. As a former Economics Department Manager at KPMG, Joshua has a deep understanding of financial operations. He is an experienced CPA with degrees in Accounting, Finance, and Economics from the University of Maryland, USA.

Dr. Ronit Shaltiel-Karyo 

VP Research & Development

Ronit is a scientific leader with a Ph.D. in Biotechnology and an MBA.
She brings extensive international experience across the pharmaceutical, cosmetic, OTC, wellness, and cannabis sectors. Her expertise spans biotechnological innovation, pharmaceutical development, medical devices, and clinical research.

Ronit is passionate about advancing breakthrough technologies and has authored multiple patents and peer-reviewed scientific publications. Beyond R&D, she has a proven track record in project management, overseeing full development lifecycles from concept through clinical studies.

Adi Mondshine

Non-Clinical Manager

Adi is a senior research scientist with over 17 years of experience in molecular biology and non-clinical research within the biopharmaceutical industry. At OrthoTreat, he serves as Non-Clinical Manager, leading in vitro and in vivo research activities supporting mechanism of action, translational insight, and preclinical development.

Adi has deep expertise in assay development, data analysis, and experimental design, and has contributed to multiple drug discovery and development programs across oncology, RNA-based therapeutics, and stem-cell technologies. He brings a rigorous, execution-focused approach to non-clinical research and team collaboration.

He holds an MSc in Biology and has spent his career translating complex biology into actionable development data.

Liya Rak

Business & Operations Associate

Liya is a business and operations associate supporting OrthoTreat’s day-to-day execution across operations, coordination, and internal projects. She brings a strong foundation in entrepreneurship and business management, with a particular interest in biotechnology and medical innovation.

Liya combines operational discipline with hands-on leadership experience. She supports cross-functional activities, stakeholder coordination, and project tracking, helping ensure smooth execution as the company scales.

She holds a degree in Entrepreneurship and Business Management, including an international exchange focused on project management and global leadership, and a professional certification in AI in Healthcare, focused on enhancing patient care and operational efficiency.

Rebecca Hebden
CMC Project Manager

Rebecca is a pharmaceutical project and CMC professional with over five years of experience across drug manufacturing, quality, and technical project management. At OrthoTreat, she serves as CMC Project Manager, supporting product development, tech transfer, and cross-functional coordination across manufacturing, regulatory, and quality activities.

Rebecca brings deep hands-on experience from GMP environments, managing complex, multi-site projects involving injectable products, clinical supply, and regulatory readiness. She is highly skilled in planning, risk management, documentation, and execution under strict timelines and specifications.

She holds an MSc in Pharmaceutical Manufacture and Quality Control and formal certification in project management.

Dr. Hilik Marom

Co-founder, Pre-Clinical Research & Innovation Director

Hilik is one of Israel’s leading veterinarians. He owns and manages the Jerusalem Veterinary Medical Center (JVMC) and is the ex-Chairman of the Israeli Companion Animal Veterinary Association (ICAVA), representing the WSAVA in Israel. Dr. Marom is a researcher and founding member of Treat Group, an incubator for health innovation. He has also completed a research fellowship at the Bone Laboratory of the Sackler School of Medicine at Tel Aviv University.